Impact of delta-sarcoglycan gene polymorphism on the occurrence of coronary spastic angina in Japanese patients with hypertrophic cardiomyopathy

Circulation Journal

Volumn 71, Issue 8, 2007, Pages 1263-1267

  Honda, Tsuyoshi ^a   Sugiyama, Seigo ^a   Sakamoto, Tomohiro ^a   Kaikita, Koichi ^a   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Coronary spastic angina; Delta sarcoglycan; Gene polymorphism; Hypertrophic cardiomyopathy

Indexed keywords

DELTA SARCOGLYCAN; SARCOGLYCAN; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY SPASM; CORONARY RISK; DNA POLYMORPHISM; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATHOGENESIS; PROVOCATION TEST;

5' UNTRANSLATED REGIONS; AGED; ANGINA PECTORIS; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY VASOSPASM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; SARCOGLYCANS;

EID: 34547573673     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1263     Document Type: Article

References (37)

1. Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet 2004; 363: 1881-1891.
2. Sorajja P, Ommen SR, Nishimura RA, Gersh BJ, Berger PB, Tajik AJ. Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease. Circulation 2003; 108: 2342-2348.
3. Maron BJ, Epstein SE, Roberts WC. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol 1979; 43: 1086-1102.
4. Waller BF, Maron BJ, Epstein SE, Roberts WC. Transmural myocardial infarction in hypertrophic cardiomyopathy: A cause of conversion from left ventricular asymmetry to symmetry and from normal-sized to dilated left ventricular cavity. Chest 1981; 79: 461-465.
5. Basso C, Thiene G, Corrado D, Buja G, Melacini P, Nava A. Hypertrophic cardiomyopathy and sudden death in the young: Pathologic evidence of myocardial ischemia. Hum Pathol 2000; 31: 988-998.
6. Kodama K, Hamada M, Kazatani Y, Matsuzaki K, Murakami E, Shigematsu Y, et al. Clinical characteristics in Japanese patients with coexistent hypertrophic cardiomyopathy and coronary vasospasm. Angiology 1998; 49: 849-855.
7. Nosaka H, Nobuyoshi M. Coronary arterial spasm and symptomatology in ischemic and non-ischemic heart diseases: Study of the ergonovine maleate provocative test in 3,000 consecutive patients. J Cardiogr Suppl 1987; 12: 35-47.
8. Nakahashi T, Naka M, Shiotani I, Nagano R, Bun T, Aoki M, et al. Vasospastic angina pectoris associated with apical hypertrophic cardiomyopathy. Intern Med 1995; 34: 436-440.
9. Suzuki N, Seto S, Koide Y, Sato O, Hirano H, Kawano H, et al. Co-existence of familial hypertrophic cardiomyopathy and vasospastic angina pectoris in two brothers. Jpn Heart J 2003; 44: 775-782.
10. Konishi T, Kondou H, Tamura T, Izumi C, Inoko M, Kitaguchi S, et al. Two cases of hypertrophic cardiomyopathy with coronary vasospasm. Jpn Circ J 1998; 62: 854-857.
11. Morito N, Ogawa M, Matsuo S, Mihara H, Miyoshi K, Yahiro E, et al. Atrial septal defect in apical hypertrophic cardiomyopathy associated with coronary spasm. Int J Cardiol 2004; 93: 339-342.
12. Roberts R, Sigwart U. Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy. Circulation 2005; 112: 293-296.
13. Hirota T, Kitaoka H, Kubo T, Okawa M, Furuno T, Doi YL. Morphologic characteristics of hypertrophic cardiomyopathy of the elderly with cardiac myosin-binding protein C gene mutations. Circ J 2006; 70: 875-879.
14. Sakamoto A, Ono K, Abe M, Jasmin G, Eki T, Murakami Y, et al. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: An animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci USA 1997; 94: 13873-13878.
15. Wheeler MT, Allikian MJ, Heydemann A, Hadhazy M, Zarnegar S, McNally EM. Smooth muscle cell-extrinsic vascular spasm arises from cardiomyocyte degeneration in sarcoglycan-deficient cardiomyopathy. J Clin Invest 2004; 113: 668-675.
16. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841-842.
17. Okumura K, Yasue H, Matsuyama K, Goto K, Miyagi H, Ogawa H, et al. Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol 1988; 12: 883-888.
18. Okumura K, Yasue H, Matsuyama K, Ogawa H, Morikami Y, Obata K, et al. Effect of acetylcholine on the highly stenotic coronary artery: Difference between the constrictor response of the infarct-related coronary artery and that of the noninfarct-related artery. J Am Coll Cardiol 1992; 19: 752-758.
19. Maruyoshi H, Kojima S, Otsuka F, Funahashi T, Kaikita K, Sugiyama S, et al. Hypoadiponectinemia is associated with coronary artery spasm in men. Circ J 2005; 69: 1154-1156.
20. Roberts R, Sigwart U. Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy. Circulation 2005; 112: 293-296.
21. Van Driest SL, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc 2005; 80: 463-469.
22. Kugiyama K, Yasue H, Ohgushi M, Motoyama T, Kawano H, Inobe Y, et al. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers. J Am Coll Cardiol 1996; 28: 1161-1167.
23. Yasue H, Kugiyama K. Coronary spasm: Clinical features and pathogenesis. Intern Med 1997; 36: 760-765.
24. Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, et al. Long-term prognosis for patients with variant angina and influential factors. Circulation 1988; 78: 1-9.
25. Tsubata S, Bowles KR, Vatta M, Zintz C, Titus J, Muhonen L, et al. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 2000; 106: 655-662.
26. Sakata K, Nawada R, Ohbayashi K, Tamekiyo H, Yoshida H. Diffuse and severe left ventricular dysfunction induced by epicardial coronary artery spasm. Angiology 2000; 51: 837-847.
27. Nishi I, Iida K, Kawano S, Masumi T, Fumikura Y, Ohtsuka S, et al. Effects of anti-vasospastic agent in Japanese patients with dilated cardiomyopathy and coronary vasospasm. Jpn Heart J 2002; 43: 333-342.
28. Suzuki S, Sugiyama S, Usuku H, Hirai N, Kaikita K, Sakashita N, et al. Heart failure with silent coronary artery spasm exhibiting microscopic focal myocardial necrosis and amyloid-deposition. Intern Med 2004; 43: 199-203.
29. Shimizu M, Kawata M, Okada T, Mizutani T. Diffuse left ventricular hypokinesis mimicking dilated cardiomyopathy with multi-vessel coronary vasospasm. J Cardiol 2000; 35: 409-415.
30. Biagini E, Coccolo F, Ferlito M, Perugini E, Rocchi G, Bacchi-Reggiani L, et al. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: Prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients. J Am Coll Cardiol 2005; 46: 1543-1550.
31. Cohn RD, Durbeej M, Moore SA, Coral-Vazquez R, Prouty S, Cambell KP. Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex. J Clin Invest 2001; 107: R1-R7.
32. Wheeler MT, Korcarz CE, Collins KA, Lapidos KA, Hack AA, Lyons MR, et al. Secondary coronary artery vasospasm promotes cardiomyopathy progression. Am J Pathol 2004; 164: 1063-1071.
33. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997; 336: 775-785.
34. Yasue H, Omote S, Takizawa A, Nagao M. Coronary arterial spasm in ischemic heart disease and its pathogenesis: A review. Circ Res 1983; 52: 147-152.
35. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 1998; 103: 65-69.
36. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, et al. T-786 - >C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99: 2864-2870.
37. Ogimoto A, Shigematsu Y, Nakura J, Hara Y, Ohtsuka T, Kohara K, et al. Endothelial nitric oxide synthase gene polymorphism (Glu298 Asp) in patients with coexistent hypertrophic cardiomyopathy and coronary spastic angina. J Mol Med 2005; 83: 619-625.